Lincomycin (X-GEN Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Lincomycin drug offered from X-GEN Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | X-GEN Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | lincomycin hydrochloride |
SUBSTANCE NAME: | LINCOMYCIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-07-05 |
END MARKETING DATE: | 0000-00-00 |
Lincomycin HUMAN PRESCRIPTION DRUG Details:
Item Description | Lincomycin from X-GEN Pharmaceuticals, Inc. |
LABELER NAME: | X-GEN Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/mL) |
START MARKETING DATE: | 2015-07-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 39822-0350_5ea7fe16-a790-42aa-ad0f-523a02981f2a |
PRODUCT NDC: | 39822-0350 |
APPLICATION NUMBER: | ANDA201746 |
Other LINCOMYCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: